Search results
My name is Brook Jackson. I am a whistleblower suing Pfizer and my former employer, Ventavia Research Group, in Federal court under the False Claims Act for fraud I witnessed during the Pfizer COVID-19 MRNA clinical trials in September 2020. I have dedicated nearly two decades of my career to ensuring the delivery of safe and effective ...
Nov 2, 2021 · After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson (video 1), emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day.
- Paul D Thacker
- 2021
Sep 1, 2023 · Brook Jackson claims she witnessed fraud and data integrity issues in Pfizer's vaccine trials at Ventavia Research Group. She sued Pfizer under the Federal False Claims Act, but the FDA and the media questioned her evidence and motives.
- Simply put, the Federal False Claims Act is the #1 way the United States Federal Government fights fraud. It is powerful as it allows whistleblower...
- A whistleblower lawsuit, also known as a qui tam lawsuit, typically involves an individual (the whistleblower) exposing fraud, corruption, or illeg...
- Essentially, it allows the person responsible for informing the government of the wrongdoing (the whistleblower) to receive a portion of the money...
- John Kopchinski is a former sales representative for Pfizer Inc., a prominent pharmaceutical company. He gained significance in whistleblowing when...
- Whistleblowers face immense challenges when exposing fraud within large corporations due to several factors:Power and resources: Large corporations...
Apr 4, 2023 · Brook Jackson, who worked as a regional director at testing sites by Pfizer contractor Ventavia, alleged several protocol violations that could have led the Food and Drug Administration to discontinue the trial. Ventavia fired Jackson shortly after she called the FDA.
- uumanah@bloombergindustry.com
- Reporter
- Who Is Brook Jackson?
- 'Unblinding Clinical Trial'
- Ventavia and Pfizer Denied Accusations
- Biontech Shares Fall by 20%
Brook Jackson is a former clinical trial auditor who was let go for 'raising her voice'. The regional director for Ventavia, Jackson was fired immediately after she reported her concerns to the US Food and Drug Administration. "After repeatedly notifying Ventavia of poor laboratory management, patient safety concerns, and data integrity issues, the...
"One photo showed needles discarded in a plastic biohazard bag instead of a container box. Another showed vaccine packaging materials with trial participants' identification numbers written on them left out in the open, potentially unblinding participants," the BMJ article stated. The Pfizer-BioNTech vaccine was authorized by the FDA in August, des...
Ventavia spokesperson Lauren Foreman discredited Jackson's claims. Foreman noted that Jackson was employed "for approximately 2 weeks in September 2020, and no part of her job responsibilities concerned the clinical trials at issue." Pfizer also released a statement and said it was "disappointed by the recent article published by the British Medica...
After the explosive whistleblower report came out, shares of BioNTech, the German company that co-developed the vaccine with Pfizer, took a drastic 20% plunge on Friday, November 5. BioNTech shares traded on the NASDAQ exchange briefly plummeted to around $60.
- 31 sec
May 1, 2024 · Court documents filed for False Claims Act Qui Tam case in Eastern District of Texas.
Dec 8, 2022 · Brook Jackson was a clinical research manager who exposed the fraud and breaches in Pfizer's COVID-19 vaccine trials. She is suing Pfizer for $1.9 billion on behalf of those injured by the vaccine.
